We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATCX
3126
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$131K ﹤0.01%
19,647
-14,803
-43% -$106K
MRK icon
3127
CALL
Merck
MRK
$326B
$130K ﹤0.01%
+1,500
New +$134K
OFS icon
3128
OFS Capital
OFS
$46.1M
$130K ﹤0.01%
15,845
-1,800
-10% -$18.6K
CORZW
3129
CALL
DELISTED
Core Scientific, Inc. Warrant
CORZW
$130K ﹤0.01%
100,000
-9,673
-9% -$4.62K
CINT icon
3130
CI&T Inc
CINT
$424M
$129K ﹤0.01%
13,735
-34,313
-71% -$364K
WKME
3131
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$128K ﹤0.01%
+15,033
New +$155K
RVP icon
3132
Retractable Technologies
RVP
$20.1M
$126K ﹤0.01%
63,529
-57,364
-47% -$200K
BRCC icon
3133
BRC Inc
BRCC
$118M
$125K ﹤0.01%
+16,071
New +$145K
LRMR icon
3134
Larimar Therapeutics
LRMR
$394M
$124K ﹤0.01%
+38,710
New +$97K
LTRX icon
3135
Lantronix
LTRX
$235M
$124K ﹤0.01%
+25,641
New +$156K
UA icon
3136
Under Armour Class C
UA
$2.98B
$124K ﹤0.01%
+20,725
New +$162K
MTRY
3137
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$124K ﹤0.01%
+12,299
New +$124K
VNET
3138
VNET Group
VNET
$1.89B
$123K ﹤0.01%
+22,300
New +$117K
CRMD icon
3139
CorMedix
CRMD
$583M
$122K ﹤0.01%
43,077
-101,114
-70% -$421K
PDD icon
3140
PUT
Pinduoduo
PDD
$122B
$119K ﹤0.01%
1,900
-199,800
-99% -$11.6M
RAIL icon
3141
FreightCar America
RAIL
$277M
$119K ﹤0.01%
32,000
CHR icon
3142
Cheer Holding
CHR
$3.58M
$118K ﹤0.01%
+53
New +$107K
CMPX icon
3143
Compass Therapeutics
CMPX
$367M
$117K ﹤0.01%
51,816
+28,089
+118% +$77.8K
OPTXW icon
3144
CALL
Syntec Optics Holdings Warrant
OPTXW
$14.1M
$117K ﹤0.01%
11,657
STRY.WS
3145
CALL
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$117K ﹤0.01%
78,481
-363,343
-82% -$91.2K
LTRYW icon
3146
CALL
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$1.01K
$116K ﹤0.01%
498,681
-36,470
-7% -$2.14K
GPGI
3147
GPGI Inc
GPGI
$4.15B
$114K ﹤0.01%
27,360
-76,174
-74% -$357K
LFST icon
3148
Lifestance Health
LFST
$4.16B
$114K ﹤0.01%
+17,231
New +$120K
SPIR.WS
3149
CALL
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$109K ﹤0.01%
100,000
ML.WS
3150
CALL
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$108K ﹤0.01%
121,227
-178,773
-60% -$37K

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.